When advertisers pushed back, it happened at the journals

After a medical journal graded all 109 drug ads running in ten leading journals against FDA standards, drug companies pulled their advertising and both editors resigned.

not yet assessed

We have not finished checking this source. No judgement either way. how we score evidence

Caveat on this rating: The domain label is load-bearing, per the verified record: the primary-sourced pressure case here (the Annals advertising pullback) is a MEDICAL-JOURNAL case, not a consumer-news case, and the body says so in those words. No news-side adjudicated case exists; no "pharma funds X% of TV news" figure has any federal or peer-reviewed basis (the viral personalization is fact-checked False, PolitiFact 2023); and the pharma advertising-revenue-to-coverage causal literature is absent. The absences print as content - presenting the journal case as a news-media case would be the overreach this row exists to avoid.

In 1992 Annals of Internal Medicine published an expert review of all 109 full-page drug ads in ten leading journals, measured against FDA standards. Several large pharmaceutical companies withdrew their advertising, an estimated $1 to $1.5 million.

Coeditors Robert and Suzanne Fletcher resigned in 1993. This is a medical-journal case, not a news case, and the distinction is load-bearing.

Significant findings

Advertising was 15.1% of total American Medical Association revenue in 2004 - $40.7 million, more than double what subscriptions brought in.

Robert Fletcher, on the record: "If you ever wondered whether they play hardball, that was a pretty good demonstration that they do."

No comparable adjudicated case at a US consumer news outlet has surfaced.

Worth asking

Professional media's dependence on drug advertising is documented and quantified. The same figure for consumer news does not exist in any federal or peer-reviewed source.

So when you next meet a claim that pharma funds some percentage of TV news, ask where the number came from. The circulating versions trace to industry press quotes, or to nothing at all.

Source

Advertising in Medical Journals: Should Current Practices Change? — Fugh-Berman A, Alladin K, Chow J (2006)

Read the source: https://doi.org/10.1371/journal.pmed.0030130

DOI: 10.1371/journal.pmed.0030130

How this was scored

Study design
not recorded
Funding
not recorded
Published in
not recorded
Sample size
not recorded
Preregistered
not recorded
Conflicts disclosed
not recorded
Independent of proponent
not recorded
Retracted
No

We have not finished checking this source, so there is no scoring to show yet. “We have not checked this yet” and “this is disputed” are different statements, so no scored band is shown rather than a low one.

Read the full scoring rubric, including what it can't tell you.

Published August 31, 2026.

Questions

How strong is the evidence behind this?

Resolv rates this source "not yet assessed". We have not finished checking this source. No judgement either way. One caveat travels with that badge: The domain label is load-bearing, per the verified record: the primary-sourced pressure case here (the Annals advertising pullback) is a MEDICAL-JOURNAL case, not a consumer-news case, and the body says so in those words. No news-side adjudicated case exists; no "pharma funds X% of TV news" figure has any federal or peer-reviewed basis (the viral personalization is fact-checked False, PolitiFact 2023); and the pharma advertising-revenue-to-coverage causal literature is absent. The absences print as content - presenting the journal case as a news-media case would be the overreach this row exists to avoid. The score is calculated from recorded facts about the source — study design, funding, publication venue, sample size, preregistration — not typed in by an editor.

What is the source for this?

Advertising in Medical Journals: Should Current Practices Change? — Fugh-Berman A, Alladin K, Chow J (2006). DOI: 10.1371/journal.pmed.0030130. The full source is linked on this page so you can read it yourself.

Is this medical advice?

This is information to bring to your prescriber, not medical advice and not a reason to change anything on your own. Nothing here is an instruction to stop or reduce a medication. If you are in crisis, call or text 988.

This is information to bring to your prescriber, not medical advice and not a reason to change anything on your own. Nothing here is an instruction to stop or reduce a medication. If you are in crisis, call or text 988.